Novartis AG (NVSEF)
96.27
+1.04
(+1.09%)
USD |
OTCM |
May 07, 14:27
Novartis Gross Profit Margin (Quarterly): 74.46% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 74.46% |
December 31, 2023 | 74.34% |
September 30, 2023 | 74.22% |
June 30, 2023 | 68.85% |
March 31, 2023 | 72.92% |
December 31, 2022 | 72.27% |
September 30, 2022 | 73.35% |
June 30, 2022 | 71.33% |
March 31, 2022 | 69.91% |
December 31, 2021 | |
September 30, 2021 | 70.54% |
June 30, 2021 | 70.56% |
March 31, 2021 | 68.18% |
December 31, 2020 | 67.64% |
September 30, 2020 | 70.07% |
June 30, 2020 | 70.50% |
March 31, 2020 | 70.71% |
December 31, 2019 | 68.61% |
September 30, 2019 | 69.75% |
June 30, 2019 | 71.67% |
March 31, 2019 | 71.62% |
December 31, 2018 | 66.06% |
September 30, 2018 | 69.59% |
June 30, 2018 | 69.47% |
March 31, 2018 | 69.09% |
Date | Value |
---|---|
December 31, 2017 | 85.28% |
September 30, 2017 | 65.94% |
June 30, 2017 | 65.92% |
March 31, 2017 | 65.17% |
December 31, 2016 | 64.39% |
September 30, 2016 | 64.61% |
June 30, 2016 | 64.89% |
March 31, 2016 | 64.34% |
December 31, 2015 | 64.47% |
September 30, 2015 | 64.85% |
June 30, 2015 | 65.21% |
March 31, 2015 | 67.38% |
December 31, 2014 | 66.93% |
September 30, 2014 | 66.76% |
June 30, 2014 | 68.61% |
March 31, 2014 | 68.31% |
December 31, 2013 | 67.51% |
September 30, 2013 | 68.03% |
June 30, 2013 | 69.22% |
March 31, 2013 | 67.58% |
December 31, 2012 | 76.82% |
September 30, 2012 | 67.41% |
June 30, 2012 | 68.30% |
March 31, 2012 | 67.77% |
December 31, 2011 | 65.87% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
67.64%
Minimum
Dec 2020
74.46%
Maximum
Mar 2024
71.05%
Average
70.56%
Median
Jun 2021
Gross Profit Margin (Quarterly) Benchmarks
Sandoz Group AG | -- |
Roche Holding AG | -- |
Bristol-Myers Squibb Co | 75.29% |
ADC Therapeutics SA | 98.49% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | 33.31% |
Return on Assets | 14.38% |
Return on Invested Capital | 21.39% |
Profit Margin (Quarterly) | 22.18% |
Operating Margin (Quarterly) | 27.83% |
Return on Net Operating Assets | 18.86% |